Hospira, Inc., a Pfizer company, is voluntarily recalling one lot of Propofol Injectable Emulsion (containing benzyl alcohol), 100mL Single Patient Use Glass Fliptop Vial; lot EA7470, to the user level due to visible particulates observed in two vials during annual examination of retention samples.
Similar Posts
Thea Pharma, Inc. – 712416 – 07/09/2025
Unapproved New Drugs/MisbrandedFukuzyu Pharmaceutical Co., Ltd. – 1/19/2024
Fukuzyu Pharmaceutical Co., Ltd. – 1/19/2024. Country: Japan. Record Type: 483BlendHouse. Reading, PA. EIR issued 06/09/2022
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 06/09/2022
Short Title (70 char) BlendHouse. Reading, PA. EIR issued 06/09/2022
FEI Number 3015728839
Firm Name BlendHouse
Record Type EIR
State PA
Establishment Type ManufacturerArterial Cannula Recall: Edwards Lifesciences Removes Arterial Cannula due to Risk of Wire Exposure
Edwards recalls arterial cannulae due to risk of wire exposure that may cause serious patient harm.Online Controlled Substances Summits
FDA hosted its fourth summit on June 8, 2023, as an integral part of FDA’s overall efforts to protect the public, including youth, from harm associated with drugs that have abuse potential.Walgreen Company – 662158 – 09/12/2023
Failure to Register and List